BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7862863)

  • 1. Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: an autoradiographic analysis.
    Tejani-Butt SM; Labow DM
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):481-6. PubMed ID: 7862863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat.
    Mendelson SD; McEwen BS
    Neuroendocrinology; 1992 Apr; 55(4):444-50. PubMed ID: 1533016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis.
    Tejani-Butt SM; Yang J; Kaviani A
    Neuroendocrinology; 1993 Jun; 57(6):1011-8. PubMed ID: 8232759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system.
    De Kloet ER; Sybesma H; Reul HM
    Neuroendocrinology; 1986; 42(6):513-21. PubMed ID: 3010158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus.
    Hensler JG; Ferry RC; Labow DM; Kovachich GB; Frazer A
    Synapse; 1994 May; 17(1):1-15. PubMed ID: 8042142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus.
    Laaris N; Haj-Dahmane S; Hamon M; Lanfumey L
    Neuropharmacology; 1995 Sep; 34(9):1201-10. PubMed ID: 8532191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative autoradiographic analyses of the time course and reversibility of corticosterone-induced decreases in binding at 5-HT1A receptors in rat forebrain.
    Mendelson SD; McEwen BS
    Neuroendocrinology; 1992 Dec; 56(6):881-8. PubMed ID: 1369598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression.
    Chalmers DT; Kwak SP; Mansour A; Akil H; Watson SJ
    J Neurosci; 1993 Mar; 13(3):914-23. PubMed ID: 8441016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
    Iben LG; Mahle CD; Yocca FD
    Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain.
    Kuroda Y; Watanabe Y; Albeck DS; Hastings NB; McEwen BS
    Brain Res; 1994 Jun; 648(1):157-61. PubMed ID: 7922518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration of 5-HT1A receptors and 5-HT uptake sites in the rat brain.
    Gobbi M; Regondi MC; Pompeiano M; Palacios JM; Mennini T
    J Chem Neuroanat; 1994 Jul; 7(1-2):65-73. PubMed ID: 7802971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat.
    Burnet PW; Michelson D; Smith MA; Gold PW; Sternberg EM
    Brain Res; 1994 Feb; 638(1-2):311-24. PubMed ID: 8199869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiographic study.
    Biegon A; Rainbow TC; McEwen BS
    Brain Res; 1985 Apr; 332(2):309-14. PubMed ID: 2986762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; VilarĂ³ MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe.
    Johnson RG; Fiorella D; Winter JC; Rabin RA
    Eur J Pharmacol; 1997 Jun; 329(1):99-106. PubMed ID: 9218690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M; Kennett GA; Curzon G
    Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M; Balducci C; Samanin R
    Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.